What is the recommended intramuscular (IM) dose of benzodiazepines (BZD) for treating catatonia in patients aged 65 and older?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 28, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Research

For catatonia in patients aged 65 and older, lorazepam (Ativan) is typically administered intramuscularly at an initial dose of 1-2 mg every 4-6 hours as needed, with a recommended starting dose of 1 mg due to increased sensitivity to benzodiazepines in elderly patients 1. The dose can be cautiously titrated upward based on response and tolerability.

  • Treatment should continue until catatonic symptoms resolve, typically within 1-3 days, after which oral benzodiazepines can be considered for maintenance.
  • Close monitoring is essential in elderly patients for respiratory depression, excessive sedation, confusion, and fall risk.
  • Lorazepam works by enhancing GABA neurotransmission, which helps reduce the abnormal neural activity underlying catatonia. If there is no response after 2-3 days of adequate benzodiazepine treatment, electroconvulsive therapy (ECT) should be considered as an alternative or adjunctive treatment, as it is highly effective for catatonia, particularly in cases resistant to benzodiazepines 2. Some patients may require long-term benzodiazepine maintenance treatment, and sudden discontinuation or non-adherence can lead to loss of response or need for higher doses 1. It is also important to note that cerebral abnormalities, medical comorbidities, and mood disorders are common in patients with catatonia, and these factors should be taken into account when developing a treatment plan 3, 2.

References

Research

Maintenance treatment of catatonia with benzodiazepines: A case series and literature review.

Neuropsychopharmacologia Hungarica : a Magyar Pszichofarmakologiai Egyesulet lapja = official journal of the Hungarian Association of Psychopharmacology, 2024

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.